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Abstract
Background: Human immunodeficiency virus type 1 (HIV-1) latency represents the major barrier to virus
eradication in infected individuals because cells harboring latent HIV-1 provirus are not affected by current
antiretroviral therapy (ART). We previously demonstrated that DNA methylation of HIV-1 long terminal repeat
(5’ LTR) restricts HIV-1 reactivation and, together with chromatin conformation, represents an important
mechanism of HIV-1 latency maintenance. Here, we explored the new issue of temporal development of DNA
methylation in latent HIV-1 5’ LTR.
Results: In the Jurkat CD4+ T cell model of latency, we showed that the stimulation of host cells contributed to
de novo DNA methylation of the latent HIV-1 5’ LTR sequences. Consecutive stimulations of model CD4+ T cell
line with TNF-α and PMA or with SAHA contributed to the progressive accumulation of 5’ LTR DNA methylation. Further,
we showed that once established, the high DNA methylation level of the latent 5’ LTR in the cell line model was a stable
epigenetic mark. Finally, we explored the development of 5’ LTR DNA methylation in the latent reservoir of HIV-1-infected
individuals who were treated with ART. We detected low levels of 5’ LTR DNA methylation in the resting CD4+ T cells of
the group of patients who were treated for up to 3 years. However, after long-term ART, we observed an accumulation of
5’ LTR DNA methylation in the latent reservoir. Importantly, within the latent reservoir of some long-term-treated
individuals, we uncovered populations of proviral molecules with a high density of 5’ LTR CpG methylation.
Conclusions: Our data showed the presence of 5’ LTR DNA methylation in the long-term reservoir of HIV-1-infected
individuals and implied that the transient stimulation of cells harboring latent proviruses may contribute, at least in part,
to the methylation of the HIV-1 promoter.
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Background
A combination of antiretroviral drugs is the current
treatment used to suppress human immunodeficiency
virus type 1 (HIV-1) replication in infected patients.
Nevertheless, the virus persists in the patient’s cellular
reservoirs, where it is able to establish latent infection.
The major HIV-1 reservoir is a small pool of latently
infected resting memory CD4+ T cells carrying an
integrated form of the viral genome [1–4]. The latent
reservoir impedes HIV-1 eradication from the organism
because under the non-productive state of infection, HIV-1
is refractory to immune surveillance and eradication by
antiretroviral therapy (ART). Although the process of
latency establishment is not yet clear, the maintenance of
the latent reservoir determines the outcome of the therapy.
Mutually cooperating mechanisms in HIV-1 transcriptional
latency include transcriptional interference, insufficient
levels of cellular transcriptional activators, chromatin con-
formation, DNA methylation, influence of the integration
site, and fluctuations in Tat protein expression.
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Once latency is established, repressive chromatin around
the HIV-1 5’ LTR is critical for the maintenance of latency
[5–13]. Considerable efforts are underway to employ agents
that induce chromatin de-repression or activation of tran-
scription for HIV-1 reactivation in vivo in cells of the latent
reservoir. It is believed that infected cells in which HIV-1
latency is reversed will be killed by the immune response or
viral cytopathic effects whereas new rounds of infection will
be prevented by ART [14–16]. Histone deacetylase (HDAC)
inhibitors, including valproic acid (VPA) and suberoylani-
lide hydroxamic acid (SAHA, Vorinostat), have been used
in attempts to purge the latent reservoir, but without ultim-
ate success [17–23]. One clinical study reported reduction
of the latent viral reservoir size in infected individuals
receiving ART and VPA treatment [24]. However, following
clinical trials using VPA or SAHA failed to progressively
reduce the frequency of infected resting CD4+ T cells [17,
18, 20–22, 25–31]. In agreement, it was demonstrated that
HDAC inhibitors, including VPA and SAHA, do not induce
HIV production in the latent viral reservoir of aviremic in-
dividuals in ex vivo system [32]. In addition, other HDAC
inhibitors, panobinostat and romidepsin, stimulated HIV-1
expression in latently infected primary cells [33], in CD4+ T
cells ex vivo and also in HIV-1-infected individuals in vivo
[34, 35]. In summary, the results of clinical trials have dem-
onstrated that the latent reservoir in vivo is reactivated only
partially, and the latency maintenance mechanisms are
therefore crucial targets for HIV-1-therapeutic strategies
(reviewed in [36]).
Another factor that cooperates with chromatin struc-
ture in HIV-1 latency maintenance is DNA methylation.
A study by Kauder et al. identified two CpG islands
flanking the HIV-1 transcription start site, the first CpG
island located in the U3 region, the second CpG island
overlapping the last nucleotide of the U5 region and 189
nucleotides downstream of the HIV-1 5’ LTR [37].
Importantly, we and others have suggested that the DNA
methylation of HIV-1 promoter/enhancer sequences is
not involved in the establishment of latency but rather
plays an important role in its maintenance [29, 37, 38].
We have shown previously in an in vitro model of HIV-1
latency and in a latent reservoir of HIV-1-infected patients
that CpG methylation of the HIV-1 5’ LTR is an additional
epigenetic restriction mechanism that controls the resist-
ance of latent HIV-1 to reactivation signals and thus
determines the stability of HIV-1 latency. However, we
have shown that methylated proviruses can be reactivated
to some extent using inhibitors of histone deacetylases
and inhibitors of DNA methylation [29]. In this context,
the DNA methylation levels of HIV-1 5’ LTR in the latent
reservoir in vivo are highly important.
The methylation status of the 5’ LTR in patients was
addressed in several studies with different outcomes. In
our previous study, we analyzed the memory CD4+ T
cells of six aviremic HIV-1-infected individuals who were
treated for 11.5 years (median), and we detected 19 to
100 % CpG methylation in the 5’ LTR [29]. In the
following studies, only 1 and 2 % of methylated CpGs in
HIV-1 5’ LTR were detected in the resting CD4+ T cells
of patients who were treated for 2.9 and 5 years, respect-
ively [39, 40]. Moreover, the peripheral blood mono-
nuclear cells (PBMCs) of long-term non-progressors
displayed 0 and 5 % methylated CpGs in the HIV-1 5’
LTR [41, 42]. Overall, the assessments of the HIV-1 5’
LTR methylation levels in the latent reservoir of ART-
treated HIV-1-infected individuals remain controversial
and require further exploration.
In this study, we focused on the development of 5’
LTR DNA methylation in latent HIV-1. To explore this
phenomenon, we took advantage of the latency cell line
model that was validated in our previous study. We
employed two Jurkat-derived cellular clones, H12 and
2D12, which harbor a latent HIV-1 “mini-provirus” (LTR-
Tat-IRES-EGFP-LTR) whose reactivation can be moni-
tored according to the percentage of EGFP-positive cells
[29]. Both clones used in the previous and present study
contained an identical and genetically unaltered single
proviral copy that was integrated at the same site of the
human genome within the intron of ubiquilin 1 gene. As
we had shown previously, clone H12 displayed a low level
of HIV-1 5’ LTR DNA methylation of the first CpG island
(7 %), and the latent provirus was easily reactivated by
various latency-reversing agents [29]. In contrast, clone
2D12 displayed a high level of 5’ LTR DNA methylation of
the first CpG island (95 %), and the latent provirus was
resistant to reactivation [29]. Importantly, the 2D12 clone
was derived from H12 cells by mitogenic phorbol-12-
myristate13-acetate (PMA) and tumor necrosis factor-α
(TNF-α) stimulation and the subsequent selection of
EGFP-negative subclones [29]. We showed that DNA
methylation in the HIV-1 5’ LTR accumulated in the
course of cell line stimulation by NF-κB inducers and
selection of EGFP-negative cells.
To study the temporal development of DNA methylation
of HIV-1 promoter we investigated whether the stimulation
of Jurkat-derived latency model cell line harboring the
HIV-1 provirus can induce DNA methylation of the 5’ LTR.
We showed in this model that repeated transient stimula-
tions of cells assisted de novo 5’ LTR DNA methylation of
the latent HIV-1 provirus. However, the high DNA methy-
lation level of the latent 5’ LTR was a stable epigenetic
mark. Finally, we measured 5’ LTR DNA methylation in the
latent reservoir of HIV-1-infected individuals who were
treated for various periods of time. We demonstrated accu-
mulation of DNA methylation in HIV-1 5’ LTR in the latent
reservoir of HIV-1-infected individuals with a long history
of ART. Our data showed that although HIV-1 5’ LTR
methylation in the resting CD4+ T cells of HIV-1-infected
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individuals was a rare event, it increased with the time of
reservoir persistence. Our results suggest that transient
cellular stimulations may contribute, at least partially, to
increase of 5’ LTR DNA methylation in the HIV-1 latent
reservoir and, therefore, may contribute to the reser-
voir stability.
Results
Cellular stimulation contributed to de novo DNA
methylation of the proviral 5’ LTR in the cell line model
The accumulation of highly methylated latent proviral
copies observed during consecutive cycles of provirus
reactivation and negative selection could be explained
either by the selection of preexisting non-reactivated
methylated proviruses or by de novo proviral 5’ LTR
DNA methylation induced in the process of TNF-α and
PMA-mediated cell stimulations. To distinguish between
these two mechanisms of provirus 5’ LTR methylation,
we performed parallel repeated stimulations of the H12
cell line with or without the subsequent selection of
EGFP-negative cells. At the time of each stimulation, we
assessed HIV-1 provirus reactivation after TNF-α and
PMA treatment according to the percentage of EGFP-
positive cells. We also performed bisulfite sequencing of
the 5’ LTR at 24 days after each stimulation, when the
cells were restored to the non-stimulated, steady state.
Our methylation analysis throughout the study con-
cerned predominantly the first CpG island positioned
upstream of the transcription start site [37]. A flowchart
of the experiment is provided in Fig. 1a.
First, we reproduced the previously mentioned experi-
ment using FACS-sorting of the EGFP-negative pool of
H12 cells that contained non-activated latent provirus.
After the first 24-h stimulation of the H12 cell line with
TNF-α and PMA, the HIV-1 latent provirus was reacti-
vated in 79 % of the cells. We sorted the remaining 21 %
of EGFP-negative cells and let the cells restore to their
non-stimulated steady state. We then repeated the stimula-
tion with TNF-α and PMA and sorted the EGFP-negative
cells (Fig. 1a). After the third cycle of stimulation, the latent
provirus was reactivated in only 25 % of the cells (Fig. 1b).
Simultaneously, the 5’ LTR methylation of the latent pro-
virus as measured by bisulfite sequencing increased from
7 % of methylated CpGs before the first stimulation and
sorting to 68 % after the third cycle of stimulation (Fig. 1c).
In parallel, we performed a series of consecutive stimu-
lations of H12 cells without sorting the EGFP-negative
cells. After the first 24-h stimulation of H12 cells with
TNF-α and PMA, the HIV-1 latent provirus was reacti-
vated in 82 % of the cells. We let the entire population of
cells containing both reactivated and non-activated HIV-1
proviruses restore to the latent EGFP-negative steady
state. We repeated this procedure five times (Fig. 1a).
After the fifth cycle of stimulation, the latent provirus was
reactivated only in 68 % of the cells (Fig. 1b). Simultan-
eously, the 5’ LTR methylation of the latent provirus in-
creased from 7 % of methylated CpGs before the first
stimulation to 34 % before the fifth stimulation (Fig. 1c).
The results showed that accumulation of 5’ LTR DNA
methylation did not require selection of EGFP-negative
cells. To gain deeper insight into the mechanism of 5’ LTR
DNA methylation accumulation we analyzed the individ-
ual 5’ LTR molecules within the methylation profile of the
H12 cells before the fifth stimulation showing the average
level of 34 % methylation (Fig. 1d). The majority of indi-
vidual 5’ LTR molecules contained less than 50 % DNA
methylation, arguing against the selection of preexisting
non-reactivated methylated molecules (Fig. 1e). In a paral-
lel culture of non-stimulated H12 cells, the hypomethy-
lated status of the HIV-1 promoter remained stable (7 %).
Our results noted that cellular stimulation with TNF-α
and PMA supported de novo CpG methylation in the 5’
LTR of both reactivated and non-activated proviruses.
Repeated cellular stimulations contributed, at least in part,
to the progressive accumulation of DNA methylation in
the latent HIV-1 promoter.
In contrast to progressive methylation of the initially
hypomethylated latent promoter, the DNA methylation
of highly methylated 2D12 5’ LTR remained stable after
consecutive activations (Additional file 1: Figure S1A).
We used the same repeated cycles of the 2D12 cells
stimulation with TNFα and PMA. Surprisingly, we did
not observe any continuous increase in the percentage
of EGFP-positive 2D12 cells during this experiment,
even after the sorting of EGFP-positive cells (Additional
file 1: Figure S1B). In accordance, we did not detect
decrease of 5’ LTR DNA methylation levels. Repeated
cycles of cellular stimulation by NF-κB inducers did not
alter the hypermethylated status of HIV-1 5’ LTR in the
2D12 cells.
Thus, we demonstrated that repeated stimulation
cycles of Jurkat-derived CD4+ T cells harboring the
latent HIV-1 provirus contributed to de novo CpG
methylation within the 5’ LTR. The density of CpG
methylation in the latent HIV-1 promoter increased
gradually with the number of cell stimulation cycles even
without the selection of EGFP-negative cells, although at
a lower rate than in the selected population. The increase
in the 5’ LTR DNA methylation level correlated with a
decreased reactivation capacity of the latent provirus by
NF-κB inducers. Furthermore, once established, the high
DNA methylation level of the HIV-1 5’ LTR remained
stable and resistant to demethylation.
Both TNF-α-PMA and SAHA stimulation increased DNA
methylation of the latent HIV-1 5’ LTR in the model cell line
Furthermore, we were interested in whether the stimulation
of CD4+ T cells with different agents used for the
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Fig. 1 (See legend on next page.)
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reactivation of HIV-1 from latency induced similar
effects on the latent provirus 5’ LTR methylation
development. We analyzed TNF-α and PMA stimula-
tion versus stimulation by SAHA. We stimulated the
H12 cell line with TNF-α and PMA or with SAHA for
24 h and sorted out the EGFP-negative cells contain-
ing non-activated latent HIV-1 provirus. T cell activa-
tion by SAHA, which was measured by the expression
of the early activation marker CD69, was substantially
less efficient (35 %) in comparison to TNF-α and PMA
stimulation (100 %, Additional file 2: Figure S2). How-
ever, reactivation of the latent HIV-1 provirus was effi-
cient in both inductions. Stimulation by TNF-α and
PMA led to EGFP expression in 90 % of H12 cells,
whereas SAHA induced EGFP in 80 % of H12 cells
(Additional file 2: Figure S2). We repeated the stimu-
lation with TNF-α and PMA or with SAHA followed
by selection of EGFP-negative cells twice. After the
second series of stimulations, the 5’ LTR DNA methy-
lation levels were significantly increased after both
treatments compared to the original level of 8 %. Fur-
ther, TNF-α and PMA induced significantly higher
increase of the 5’ LTR DNA methylation (64 %) com-
pared to SAHA (31 %), (p = 0.001; Fig. 2a).
In addition to the average DNA methylation, the level
of CpG methylation of individual HIV-1 promoters
could serve as a hallmark of proviral activity. In Fig. 2b,
we showed the distribution of 5’ LTR molecules with
increasing counts of methylated CpG dinucleotides
within each molecule. In the non-stimulated culture of
H12 cells, the HIV-1 promoter sequences with one meth-
ylated CpG were the most prevalent whereas 5’ LTR
sequences with two or three methylated CpGs were rare
(Fig. 2b). In contrast, in H12 cells stimulated with TNF-α
and PMA, HIV-1 promoters with seven methylated CpGs
prevailed, and many 5’ LTR molecules contained at least
nine methylated CpGs out of 14 CpG dinucleotides
(Fig. 2b). In H12 cells that were stimulated with
SAHA, the distribution of methylated CpG was bimodal;
this group of promoters showed a hypomethylated peak
with one, two, or three methylated CpGs and another
peak with five or six methylated CpGs, the maximal level
being eight methylated CpGs in one molecule (Fig. 2b). In
conclusion, a new category of 5’ LTR molecules with
densely methylated CpGs were present in the TNF-α and
PMA-stimulated EGFP-negative cell population in com-
parison with the non-stimulated cells.
Finally, we analyzed the patterns of 5’ LTR DNA
methylation. The DNA methylation levels at the individual
CpG dinucleotides (Fig. 2c) were significantly different at
seven CpGs in TNF-α and PMA-stimulated H12 cells com-
pared to SAHA-stimulated H12 cells. We observed an
intriguing situation at the NF-κB binding site concerning
CpG nos. 6 and 7. CpG no. 6 was the only one of 14 CpGs
(See figure on previous page.)
Fig. 1 Cellular stimulation contributes to de novo DNA methylation of proviral 5’ LTR in the H12 cell line. a Flowchart of repeated stimulations
of the H12 cell line with TNF-α and PMA performed with or without the selection of EGFP-negative cells by FACS-sorting. At the time of each stimulation,
HIV-1 provirus reactivation after 24-h of TNF-α and PMA treatment was assessed according to the percentage of EGFP-positive cells. Bisulfite sequence
determined the level of 5’ LTR CpG methylation. Bisulfite sequencing of the 5’ LTR was performed at 24 days after each stimulation, when the cells were
restored to the non-stimulated, steady state. We assume the level of 5’ LTR DNA methylation controls the reactivation efficiency, however, the changes in
5’ LTR DNA methylation levels are not instant. Therefore, the levels of 5’ LTR methylation are determined immediately before the next stimulation cycle,
e.g., the % of the 5’ LTR methylation depicted at the stimulation number 2 (Fig. 1c) is determined immediately before the 2nd stimulation cycle, when the
cells after the first stimulation re-established the non-stimulated, basal phenotype and displayed only basal levels of EGFP and CD69. Three cycles of cellular
stimulations followed by the selection of EGFP-negative cells by FACS-sorting were performed, including three measurements of % EGFP-positive cells and
four determinations of % CpG methylation. The last % CpG methylation was measured after the third stimulation, when the cells restored the
non-stimulated steady state. Five cycles of cellular stimulations without selection of EGFP-negative cells were performed, including five measurements
of % EGFP-positive cells and five determinations of % CpG methylation. The last % CpG methylation was measured 24 days after the fourth stimulation
when the cells restored non-stimulated steady state. (The % CpG methylation 24 days after the fifth stimulation was not determined). b Latent HIV-1
provirus reactivation in the H12 cell line after repeated stimulations of cells. The H12 cell line was stimulated with TNF-α and PMA for 24 h,
and the percentage of EGFP-positive cells was determined by FACS. The number of successive stimulations is depicted on the x-axis, and the
percentage of EGFP-positive cells is depicted on the y-axis. The solid line shows activations without selection of EGFP-negative cells whereas
the dashed line indicates activations followed by selection of EGFP-negative cells. c Latent HIV-1 provirus CpG methylation levels in the H12 5’
LTR sequences after repeated stimulations of cells. The percentage of methylated CpGs in the 5’ LTR was determined by bisulfite sequencing.
The number of successive stimulations is depicted on the x-axis whereas the mean percentage of methylated CpGs is depicted on the y-axis.
The solid line shows activations without selection of EGFP-negative cells, and the dashed line indicates activations followed by selection of
EGFP-negative cells. The last point of the solid line applies to Fig. 1de. d The CpG methylation profile of the 5’ LTR in non-stimulated H12 cells
before the fifth cycle of 24-h stimulation with TNF-α and PMA. The cycles of cellular stimulations were performed without selection of EGFP-negative cells.
A schematic representation of the CpG dinucleotide distribution in 5’ LTR of the pEV731 vector together with the corresponding transcription
factor binding sites is shown. Analysis of the promoter molecules is shown as a linear array of open circles representing non-methylated CpG
residues and closed circles representing methylated CpG residues. Each line represents one sequenced molecule of the 5’ LTR. The methylation level is
presented as a mean percentage of methylated CpGs (mCpGs) in HIV-1 promoters. e Distribution of the 5’ LTR molecules according to the proportion
of methylated CpGs contained within. Non-stimulated H12 cells before the fifth cycle of 24-h stimulation with TNF-α and PMA are depicted. The cycles
of cellular stimulations were performed without selection of EGFP-negative cells. The percentage of the respective molecules is shown on the x-axis.
The total counts of methylated CpGs per molecule are shown on the y-axis
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Fig. 2 Both TNF-α-PMA and SAHA stimulation increase DNA methylation of the latent HIV-1 5’ LTR in the H12 cell line. a The CpG methylation
profiles of the 5’ LTR in non-stimulated H12 cells and EGFP-negative H12 cells selected after a 24-h stimulation with TNF-α and PMA or with SAHA.
A schematic representation of CpG dinucleotide distribution in the 5’ LTR of the pEV731 vector together with the corresponding transcription factor
binding sites is shown. An analysis of the promoter molecules is shown as a linear array of open circles representing non-methylated CpG residues
and closed circles representing methylated CpG residues. Each line represents one sequenced molecule of the 5’ LTR. The methylation levels
are presented as a mean percentage of methylated CpGs (mCpGs) in HIV-1 promoters. The p values were calculated by the non-parametric
Kruskal-Wallis test. Significance *** was assigned for p values <0.001. b Distribution of the 5’ LTR molecules according to the proportion of
methylated CpGs contained within. Non-stimulated H12 cells and EGFP-negative H12 cells selected after a 24-h stimulation with TNF-α and
PMA or with SAHA are depicted. The percentage of respective molecules is shown on the x-axis. The total counts of methylated CpGs per molecule are
shown on the y-axis. c Percentage of methylated CpGs within individual positions of CpGs. Non-stimulated H12 cells and EGFP-negative H12 cells selected
after a 24-h stimulation with TNF-α and PMA or with SAHA are depicted. Individual CpG positions are shown on the x-axis; a schematic representation of
CpG dinucleotides in the 5’ LTR of the pEV731 vector together with the corresponding transcription factor binding sites is shown below
the x-axis. The percentage of methylated CpGs is shown on the y-axis. The p values were calculated by Fisher’s exact test. Significance was
assigned as follows: * for p values <0.05, ** for p values <0.01
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that did not display increased DNA methylation after any
type of cell stimulation. DNA methylation at CpG no. 7
was significantly increased in latent proviruses after stimu-
lation with TNF-α and PMA but not after stimulation with
SAHA (p < 0.01).
In summary, we have shown that stimulation of CD4+
T cells with both TNF-α and PMA or SAHA followed by
EGFP-negative cell selection induced a significant accu-
mulation of DNA methylation at the 5’ LTR of the latent
HIV-1 provirus. In accordance with more efficient cellu-
lar stimulation, TNF-α and PMA contributed to signifi-
cantly higher DNA methylation of the 5’ LTR than the
SAHA treatment.
Hypermethylation of 5’ LTR DNA in the HIV-1 latency
model cell line is maintained by DNMT1
Assuming the role of provirus 5’ LTR DNA methylation
in the maintenance of HIV-1 latency, we explored the
stability of HIV-1 5’ LTR hypermethylation in the 2D12
cell line. We knocked down the expression of DNA
methyltransferase 1 (DNMT1) by siRNA (siDNMT1)
and analyzed the effect of DNMT1 knockdown on the
HIV-1 provirus reactivation by NF-κB inducers and its 5’
LTR DNA methylation level.
We observed the depletion of DNMT1 both at the
protein and mRNA level 3 and 6 days after transfection
(p < 0.05 for mRNA level; Fig. 3a). The DNMT1 knock-
down did not activate latent HIV-1 provirus expression
in the non-stimulated 2D12 cell line (0 % of EGFP-
positive cells; Fig. 3b, left column); however, 6 days after
the transfection, there was a more efficient provirus
reactivation after stimulation by TNF-α and PMA in the
DNMT1 knocked down cells compared to the 2D12
cells that were transfected with siCTRL (45 versus 34 %;
p < 0.01; Fig. 3b, right column). Furthermore, the
DNMT1 knockdown did not change the percentage of
stimulated CD4+ T cells (97 % of CD69-positive cells),
and the provirus was reactivated in CD69-positive cells
(Additional file 3: Figure S3). The transfection of control
siRNA (siCTRL) did not affect the provirus reactivation
in either the non-stimulated cells or in the TNF-α- and
PMA-stimulated 2D12 cells (Fig. 3b).
We estimated the changes in the 5’ LTR methylation
level as a direct effect of the DNMT1 knockdown. Using
bisulfite sequencing, no decrease in the 5’ LTR methyla-
tion was observed after siCTRL transfection. We detected
a mild decrease of 5’ LTR CpG methylation in 2D12 cells
after the DNMT1 knockdown. The 5’ LTR DNA methyla-
tion was reduced by 17 % 6 days after transfection of
siDNMT1 (p < 0.001; Fig. 3c).
Next, we performed a knockdown of DNA methyltrans-
ferase 3B, DNMT3B, using siRNA (siDNMT3B). We veri-
fied the depletion of DNMT3B in the 2D12 cell line at both
the mRNA and protein levels (Fig. 4a). The DNMT3B
knockdown did not induce provirus reactivation. TNF-α
and PMA stimulation slightly increased provirus reactiva-
tion in siDNMT3B-transfected 2D12 cells 6 days after
transfection, by 7 % compared to siCTRL-transfected cells
(Fig. 4b). We did not observe any decrease in 5’ LTR DNA
methylation in the 2D12 cells with depleted DNMT3B
6 days after transfection (Fig. 4c).
These results show that the high methylation level of
the latent 5’ LTR is partially reduced in cells with DNMT1
depletion. However, we observed no effect of DNMT3B
depletion, suggesting a role for DNMT1 in the mainten-
ance of 5’ LTR hypermethylation in the 2D12 model cell
line. In accordance with our previous results, the reduc-
tion of the 5’ LTR methylation level of the provirus corre-
lated with the increased reactivation capacity of the latent
HIV-1 after activation with TNF-α and PMA.
5’ LTR DNA methylation is resistant to HDAC2 depletion
in the HIV-1 latency model cell line
We described earlier that latency of the hypermethylated
proviral promoter in 2D12 cells was associated with the
repressive chromatin marks H3K9 me3 and H3K27 me3.
In contrast, 2D12 provirus reactivation by NF-κB in-
ducers was followed by an increase in H3 acetylation
at the 5’ LTR [29]. We analyzed the reactivation cap-
acity and 5’ LTR DNA methylation level of the 2D12
provirus after histone deacetylase (HDAC) knockdown
by siRNAs. The expression of HDAC1 and HDAC2,
which are prominent HDACs in the 2D12 cell line
(Additional file 4: Figure S4), was targeted by siRNA.
The expression of both HDAC1 (Fig. 5a) and HDAC2
(Fig. 5b) was significantly decreased at the mRNA
level 3 and 6 days after siRNA transfection (p < 0.001).
The HDAC1 knockdown did not exert any effects on
provirus reactivation in either the non-stimulated or in
stimulated 2D12 cells (Fig. 5c). The HDAC2 knockdown
did not induce latent provirus reactivation in non-
stimulated 2D12 cells (Fig. 5c, left column). However,
6 days after transfection TNF-α and PMA stimulation
reactivated the latent provirus in 46 % of 2D12 cells
with knocked down HDAC2 compared to 34 % of
siCTRL-transfected cells or 30 % of non-transfected
2D12 cells (p < 0.01; Fig. 5c, right column). We did not
observe any significant decrease in the proviral 5’ LTR
DNA methylation level after HDAC2 knockdown in
the 2D12 cell line. The 2D12 cells that were trans-
fected with siRNAs targeting HDAC2 displayed 94 %
methylated CpGs in the 5’ LTR, which was comparable
with the 92 % that was found in 2D12 cells transfected
with control siRNA (Fig. 5d).
In accordance with our previous findings showing the
importance of both DNA methylation and chromatin
deacetylation for HIV-1 latency maintenance, the depletion
of HDAC2 led to the partial reactivation of the HIV-1
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Fig. 3 Hypermethylation of 5’ LTR DNA in the HIV-1 latency model cell line is maintained by DNMT1. a DNMT1 protein expression in 2D12 cell
lines that were transfected with siCTRL and with siDNMT1 at days 3 and 6 after transfection as determined by the specific antibody is depicted
on the left panel (upper band). Equal protein loading was verified by anti-γ-tubulin antibodies as depicted on the left panel (lower band). The
DNMT1 relative mRNA levels at days 0 (control), 3, and 6 of siCTRL or siDNMT1 transfection in the 2D12 cell line as determined by qRT-PCR are
shown in the right panel. mRNA expression was normalized to the expression of the RNA polymerase II, polypeptide A (POLR2A) housekeeping
gene. The data are presented as the mean ± SD of technical triplicates. Three independent experiments were performed, representative example
is shown. The p values were calculated by the non-paired Student’s t test. Significance * was assigned for p values <0.05. b Latent HIV-1 provirus
reactivation levels after 6 days of DNMT1 knockdown. 2D12 cells were transfected with siCTRL or with siDNMT1. The left column of histograms
represents analyses without cellular stimulation whereas the right column represents histograms after 24 h of TNF-α and PMA stimulation. Three
FACS analyses of three independent experiments are overlaid; the mean percentage of EGFP-positive cells is shown above the bar. The p values
were calculated by the non-paired Student’s t test. Significance *** was assigned for p values <0.001. c CpG methylation profile of 5’ LTR in non-stimulated
2D12 cells. The methylation profiles were obtained from cells transfected with siCTRL or those transfected for 3 and 6 days with siDNMT1. Methylation
levels are presented as a mean percentage of methylated CpGs (mCpGs) in HIV-1 promoters. An analysis of promoter molecules is shown as a linear array
of open circles representing non-methylated CpG residues and closed circles representing methylated CpG residues. Each line represents one sequenced
molecule of the 5’ LTR. Mixture of genomic DNA isolated from three independent experiments was used for bisulfite analysis. The rectangle schematically
represents the 5’ LTR regions U3, R, and U5 with individually analyzed CpG dinucleotides and transcription factor binding sites. The p values were calculated
by the non-parametric Kruskal-Wallis test. Significance *** was assigned for p values <0.001
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Fig. 4 Hypermethylation of 5’ LTR DNA in the HIV-1 latency model cell line 2D12 is not maintainted by DNMT3B. a DNMT3B protein expression in
2D12 cell lines that were transfected with siCTRL and with siDNMT3B at days 3 and 6 after transfection as determined by the specific antibody is
depicted on the left panel (upper band). Equal protein loading was verified by anti-γ-tubulin antibodies as depicted on the left panel (lower band).
The DNMT3B relative mRNA levels at days 0 (control), 3, and 6 of siCTRL or siDNMT3B transfection in the 2D12 cell line as determined by qRT-PCR
are shown in the right panel. mRNA expression was normalized to the expression of the RNA polymerase II, polypeptide A (POLR2A) housekeeping
gene. The data are presented as the mean ± SD of technical triplicates. Three independent experiments were performed, representative example
is shown. The p values were calculated by the non-paired Student’s t test. Significance *** was assigned for p values <0.001. b Latent HIV-1 provirus
reactivation levels after 6 days of DNMT3B knockdown. 2D12 cells were transfected with siCTRL or with siDNMT3B. The left column of
histograms represents analyses without cellular stimulation whereas the right column represents histograms after 24 h of TNF-α and PMA
stimulation. Three FACS analyses of three independent experiments are overlaid; the mean percentage of EGFP-positive cells is shown
above the bar. The p values were calculated by the non-paired Student’s t test. Significance *** was assigned for p values <0.001. c CpG
methylation profile of 5’ LTR in non-stimulated 2D12 cells. The 5’ LTR methylation profiles were obtained from cells transfected with siCTRL
or those transfected for 3 and 6 days with siDNMT3B. Methylation levels are presented as a mean percentage of methylated CpGs (mCpGs)
in HIV-1 promoters. An analysis of promoter molecules is shown as a linear array of open circles representing non-methylated CpG residues
and closed circles representing methylated CpG residues. Each line represents one sequenced molecule of the 5’ LTR. Mixture of genomic
DNA isolated from three independent experiments was used for bisulfite analysis. The rectangle schematically represents the 5’ LTR regions
U3, R, and U5 with individually analyzed CpG dinucleotides and transcription factor binding sites.
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Fig. 5 5’ LTR DNA methylation is resistant to HDAC depletion in the HIV-1 latency model cell line. a HDAC1 relative mRNA levels at days 0 (control), 3,
and 6 after siCTRL or siHDAC1 transfection in the 2D12 cell line as determined by qRT-PCR. mRNA expression was normalized to the expression of the
RNA polymerase II, polypeptide A (POLR2A) housekeeping gene. The data are presented as the mean ± SD of technical triplicates. Three independent
experiments were performed, representative example is shown. The p values were calculated by the non-paired Student’s t test. Significance *** was
assigned for p values <0.001. b HDAC2 relative mRNA levels at days 0 (control), 3, and 6 after siCTRL or siHDAC2 transfection in the 2D12 cell
line determined by qRT-PCR. mRNA expression was normalized to the expression of the RNA polymerase II, polypeptide A (POLR2A) housekeeping gene.
The data are presented as the mean ± SD of technical triplicates. Three independent experiments were performed, representative example is
shown. The p values were calculated by the non-paired Student’s t test. Significance *** was assigned for p values <0.001. c Latent HIV-1 provirus reactivation
levels after 6 days of HDAC2 and HDCA1 knockdown. 2D12 cells that were transfected with siCTRL or with siHDAC2 and siHDAC1 are shown, either without
cellular stimulation (left column) or after 24 h of TNF-α and PMA stimulation (right column). Three FACS analyses of three biological replicates are overlaid; the
mean percentage of EGFP-positive cells is shown on the x-axis, whereas the mean fluorescence intensity of EGFP is shown on the y-axis. The p values were
calculated by the non-paired Student’s t test. Significance *** was assigned for p values <0.001. d CpG methylation profile of 5’ LTR in the non-stimulated
2D12 cell line. Latent HIV-1 provirus CpG methylation levels at the 5’ LTR sequences after 6 days of HDAC2 knockdown in the 2D12 cell line. Methylation levels
are presented as a mean percentage of methylated CpGs (mCpGs) in HIV-1 promoters. An analysis of promoter molecules is shown as a linear array of open
circles representing non-methylated CpG residues and closed circles representing methylated CpG residues. Each line represents one sequenced molecule of
the 5’ LTR. Mixture of genomic DNA isolated from three independent experiments was used for bisulfite analysis. The rectangle schematically represents the
5’ LTR regions U3, R, and U5 with individually analyzed CpG dinucleotides and transcription factor binding sites
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provirus with a hypermethylated 5’ LTR after TNF-α and
PMA stimulation. However, in our CD4+ T cell line model,
we observed no effect of HDAC2 knockdown on the
methylation level of the latent HIV-1 provirus 5’ LTR,
which remained stable.
DNA methylation of HIV-1 5’ LTR in the latent reservoir of
ART-treated patients
Next, we focused on HIV-1 5’ LTR DNA methylation
development directly in HIV-1-infected individuals. To
study the early development of HIV-1 5’ LTR methylation
in the latent reservoir of resting CD4+ T cells, we enrolled a
cohort of 15 HIV-1-infected individuals who were effect-
ively treated by antiretroviral therapy for 9 to 35 months
(median 27.5 months, Additional file 5: Table S1). We sup-
posed that under effective ART, resting CD4+ T cells con-
taining the HIV-1 provirus represented the major latent
reservoir. We isolated the resting CD4+ T cells from patient
PBMCs and analyzed the HIV-1 5’ LTR methylation levels
by bisulfite sequencing (Additional file 6: Figure S5). We
detected low levels of 5’ LTR methylation (median 2 %
methylated CpGs), with a maximum of 8 % methylation of
the 5’ LTR (Fig. 6a). Of note, we observed significant
increase in 5’ LTR DNA methylation during prolonged
therapy (p < 0.05; Fig. 6a; Additional file 5: Table S1).
The 5’ LTR methylation profile was exemplified by
individual no. 10 with 8 % of 5’ LTR methylation
(Fig. 6b). None of the analyzed patients contained more
than two methylated CpGs in one 5’ LTR molecule. This
indicated that highly methylated proviral molecules,
which are expected to be resistant to reactivation, do not
accumulate in the latent reservoir of patients who are
treated for up to 3 years. The positions of the methylated
CpGs within the 5’ LTR did not show any site-specific
patterns. In some individuals, we observed polymorphisms
of the 5’ LTR sequences including mutations of individual
CpG dinucleotides. For example, all 5’ LTR sequences of
patient no. 10 lacked the third CpG (Fig. 6b). Mutations in
the 5’ LTR may generate defective proviruses. Such pro-
viruses were shown to be preferentially methylated.
However, we detected low methylation levels of provi-
ruses with altered CpG dinucleotide patterns.
In addition, we determined CpG methylation within
the envelope coding region comprising a CpG island
that does not contribute to the regulation of viral tran-
scription [39]. Three HIV-1-infected individuals dis-
played variable levels of DNA methylation ranging from
8 to 75 % CpG methylation in resting CD4+ T cells
showing that analyzed HIV-1 DNA can be methylated
(Fig. 6c). It also suggests that HIV-1 proviruses are sub-
jected to the DNA methylation in infected individuals,
Fig. 6 5’ LTR and env methylation levels of the HIV-1 provirus in the latent reservoir of infected patients who were treated for up to 3 years. a
Levels of HIV-1 5’ LTR methylation in patients who were treated for up to 3 years. Each diamond represents one patient. The time (months) spent
undergoing therapy is depicted on the x-axis whereas the percentage of methylated CpGs in the HIV-1 5’ LTR in the latent reservoir of infected
patients is depicted on the y-axis. The methylation levels are presented as a mean percentage of methylated CpGs in HIV-1 promoters. Temporal
increase in 5‘LTR DNA methylation was statistically significant (p < 0.05) as determined by standard significance test in loglinear model. b Illustrative
example of the latent HIV-1 provirus CpG methylation profile at the 5’ LTR sequence of patient no. 10. The methylation level is presented as a mean
percentage of methylated CpGs (mCpGs) in HIV-1 promoters. An analysis of promoter molecules is shown as a linear array of open circles representing
non-methylated CpG residues and closed circles representing methylated CpG residues. Each line represents one sequenced molecule of the 5’ LTR.
The rectangle schematically represents the 5’ LTR region U3 with individually analyzed CpG dinucleotides and transcription factor binding sites. c Levels
of HIV-1 env methylation in selected patients who were treated for up to 3 years. The methylation levels are presented as a mean percentage
of methylated CpGs (mCpGs) in HIV-1 env region. An analysis of env molecules is shown as a linear array of open circles representing non-methylated
CpG residues and closed circles representing methylated CpG residues. Each line represents one sequenced env molecule. The rectangle schematically
represents the analyzed env region
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but are protected within the region important for tran-
scriptional regulation.
Taken together, and in agreement with previous re-
ports, we found low methylation levels of HIV-1 5’ LTR
in the latent reservoir of infected individuals who were
treated for a maximal period of 35 months.
DNA methylation of HIV-1 5’ LTR in the latent reservoir of
patients with a long history of ART
To further explore the long-term (LT) development of 5’
LTR methylation in the latent reservoir of HIV-1-
infected individuals, we enrolled another cohort of 10
patients who were treated for 3 to 22 years (median
12.5 years; Additional file 7: Table S2). The DNA methy-
lation analysis of HIV-1 5’ LTR, which was performed in
the same manner as in the first cohort, showed different
levels of methylation ranging from 0 to 45 % methylated
CpGs (Fig. 7a). The highest result, 45 % methylated
CpGs, was found in a single patient (no. LT1); three
other patients displayed 10, 15, and 19 % methylated
CpGs, respectively, and six patients displayed between 0
and 3 % methylated CpGs in the 5’ LTR (Fig. 7b). In sev-
eral individuals, we also analyzed the HIV-1 5’ LTR
methylation levels in isolated memory CD4+ T cells. We
obtained identical results for both memory and resting
CD4+ T cell populations (data not shown). As in the
group of patients treated for up to 3 years, the CpG
methylation within the envelope coding region of four
long-term-treated individuals displayed variable levels of
CpG methylation ranging from 10 to 74 % (Fig. 7c). In
the latent reservoir of three patients with high or moder-
ate average 5’ LTR DNA methylation levels, we detected
both heavily methylated and non-methylated 5’ LTR
molecules within the same individual (patient nos. LT1,
LT5, and LT10). Methylated 5’ LTR sequences of the
long-term treated patients did not display large rear-
rangements or mutations of CpG dinucleotides (Fig. 7b).
However, mutated 5’ LTR CpG dinucleotides were de-
tected in 5’ LTR sequences with low methylation levels
in patient nos. LT4 and LT9 (Fig. 7b). As for the previ-
ous cohort, our results do not correspond with the pref-
erential methylation of defective 5’ LTRs of the HIV-1
provirus. Finally, in the highly methylated 5’ LTRs in
patient nos. LT5 and LT10, we observed a lack of methy-
lation at the CpG located within the NF-κB binding site
which was identical with the hypomethylated CpG in the
model cell lines. When we evaluated the 5’ LTR CpG
methylation levels from all patients fused into one
group, we found a statistically significant increase of the
5’ LTR DNA methylation levels (Additional file 8: Figure
S6, p < 0,001). The percentage of methylated cytosines
contained in the 5’ LTR arose by 7.5 % of its original
value per year.
In summary, long-term ART contributed to the accumu-
lation of CpG methylation in 5’ LTR in the HIV-1 latent
reservoir. Furthermore, densely methylated 5’ LTR mole-
cules could be found within the latent reservoirs of patients
with a long history of ART. Our results in infected individ-
uals are also supported by the progressive increase of 5’
LTR CpG methylation in the Jurkat cell line model.
Discussion
Our results from the T cell model of HIV-1 latency
showed that repeated transient stimulations of cells with
TNF-α and PMA, which occurred via PKC and NF-κB
and caused efficient T cell activation [43–45], contributed,
at least partially, to de novo DNA methylation of the 5’
LTR. Furthermore, stimulation with SAHA, which did not
cause global activation of resting T cells [32, 33], also sup-
ported accumulation of DNA methylation of the 5’ LTR,
although at a lower rate than TNF-α and PMA stimula-
tion. It should be noted, however, that in contrast to the
reservoir of infected individuals, our Jurkat-derived model
cell lines H12 and 2D12 harbored the HIV-1 mini-virus.
Nevertheless, in our present work, we observed the long-
term accumulation of 5’ LTR DNA methylation in the
latent reservoir of HIV-1-infected individuals. In the
group of 10 long-term-treated patients, we detected four
individuals with 10 to 45 % methylated CpGs in the latent
HIV-1 5’ LTR. We suggest that 5’ LTR DNA methylation
may accumulate in rare proviral copies in the latent reser-
voir of HIV-1-infected individuals as a result of transient
stimulations of reservoir cells.
Accumulation of 5’ LTR DNA methylation in vivo as a
result of transient stimulations of reservoir cells could,
paradoxically, be provoked by therapeutic reactivation
approaches. However, exact mechanism of accumulation
of DNA methylation in the latent reservoir of HIV-1-
infected individuals is not clear. The high concentration
of deamination-prone methylcytosines in the proviral 5’
LTR may lead to the higher mutation rates in the latent
promoter. This mechanism may render the provirus de-
fective for replication, or it may relieve transcriptional
silencing [46].
Accumulation of the methylated 5’ LTR sequences in
the stimulated H12 cells and in the long-term reservoir
of HIV-1-infected individuals is compatible with de novo
methylation of the HIV-1 promoter or with selective
survival of cells bearing profoundly latent, methylated
proviruses. It was recently estimated in vivo that antigenic
or weak random stimulation of the host cells initiates viral
replication in the HIV-1 reservoir once every 5–8 days
[47]. A limited number of stimulated HIV-1 reservoir cells
can survive and possibly restore the resting phenotype
[48–50]. Thus, according to both proposed mechanisms
the CD4+ T cell stimulation-mediated accumulation of 5’
LTR DNA methylation would be a rare event, increasing
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Fig. 7 5’ LTR and env methylation levels of the HIV-1 provirus in the latent reservoir of long-term treated HIV-1-infected individuals. a The levels
of HIV-1 5’ LTR methylation in long-term treated patients. Each diamond represents one patient. The time (years) spent undergoing therapy is
depicted on the x-axis whereas the percentage of methylated CpGs in the 5’ LTR of HIV-1 in the latent reservoir of infected patients is depicted
on the y-axis. The methylation levels are presented as a mean percentage of methylated CpGs in HIV-1 promoters. b Latent HIV-1 provirus CpG
methylation profiles at the 5’ LTR sequences of long-term treated patients nos. LT1 to LT10. The methylation levels are presented as a mean percentage of
methylated CpGs (mCpGs) in HIV-1 promoters. An analysis of promoter molecules is shown as a linear array of open circles representing non-methylated
CpG residues and closed circles representing methylated CpG residues. Each line represents one sequenced molecule of the 5’ LTR. The
rectangle schematically represents the 5’ LTR region U3 with a distribution of individually analyzed CpG dinucleotides and transcription
factor binding sites. c Levels of HIV-1 env methylation in selected long-term-treated individuals. The methylation levels are presented as a
mean percentage of methylated CpGs mCpGs) in HIV-1 env region. An analysis of env molecules is shown as a linear array of open circles
representing non-methylated CpG residues and closed circles representing methylated CpG residues. Each line represents one sequenced
env molecule. The rectangle schematically represents the analyzed env region.
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its probability with the time of the HIV-1 reservoir
persistence.
Specifically, in the Jurkat-derived model cell line, the sub-
set of stimulated H12 cells that harbored the reactivated
provirus could be selectively destroyed by cytotoxic effects
of the viral protein products, TAT, or even EGFP. In this
case, the increase in 5’ LTR DNA methylation levels would
not be caused by de novo CpG methylation but rather by
selection for preexisting non-reactivable hypermethylated
proviral 5’ LTRs that would lack expression of the viral
proteins. To gain deeper insight into the situation, we
compared the 5’ LTR methylation profiles of the H12 cells
after consecutive series of TNF-α and PMA stimulations
performed with or without selection of EGFP-negative cells.
The methylation profile of 5’ LTR in the H12 cells without
selection of EGFP-negative cells (mean percentage 34 %
CpG methylation) did not display prevalence of hyper-
methylated molecules (Fig. 1d); the majority of 5’ LTR mol-
ecules contained less than half of methylated CpGs per
molecule (Fig. 1e). In contrast, the H12 cells that went
through the selection of EGFP-negative cells displayed the
majority of highly methylated 5’ LTR molecules (Fig. 2b,
middle panel) that would be anticipated in the case of selec-
tion of the preexisting hypermethylated molecules. We
suggest that in the H12 model cell line, de novo methyla-
tion of the 5’ LTR after cellular stimulations with TNF-α
and PMA contributes, at least in part, to the progressive
accumulation of the 5’ LTR DNA methylation.
Significant alterations of the DNA methylation landscape
and chromatin conformation at the genome-wide level
occur during T cell stimulation, differentiation and develop-
ment. Recent study showed that both DNA demethylation
and de novo methylation events occurred throughout the
maturation of human thymocytes although DNA demethyl-
ation prevailed over de novo methylation. Furthermore,
DNA methylation changes in a particular CpG site took
place generally only once during development of thymo-
cytes and were stable in subsequent differentiation stages
[51]. In mouse model, more than 1100 differentially meth-
ylated regions were identified comparing naïve and memory
CD4+ T cells exposed to specific antigen demonstrating a
link between T cell methylation status and T cell differenti-
ation [52]. Analysis of unstimulated naïve and memory
CD4+ cells from human healthy donors showed that CD4+
memory T cells were hypomethylated compared with
naïve cells [53]. Another survey demonstrated that glo-
bal DNA demethylation occurred rapidly (within 6 h)
in mouse CD4+ T cells following their activation with
PMA/Ionomycin [54]. On the other hand, immune acti-
vation of human naïve CD4+ T cells with anti-CD3/
CD28 did not reveal any significant changes in DNA
methylation of the promoter regions within 48 h of
activation [53] despite reports suggesting that such
changes occur in several genes, including IL2 and IFNγ
[55–57]. Furthermore, it was showed that there is a very
rapid and reversible increase in global CpG methylation
after PHA/IL-2 stimulation of human PBMCs [58]. Thus,
remodeling of the methylation landscape appears to occur
throughout CD4+ T cells differentiation and following
CD4+ T cells activation. It is believed that MBD proteins
play a central role in the cellular readout of DNA methyla-
tion. Methyl-CpG binding protein 2 (MBD2) is thought of
as a reader of the mCpG signature that recruits or associ-
ates with the NuRD co-repressor complex containing
histone deacetylases, which in turn reinforces transcrip-
tional silencing [59, 60].
Inhibitors of HDAC were reported to have various
effects on the global DNA methylation. Inhibitor of DNA
methyltransferases, decitabine, and inhibitor of HDAC,
SAHA, were demonstrated to target distinct and non-
overlapping regions of the genome in the human colorec-
tal cell lines [61]. Another HDAC inhibitor, romidepsin,
had essentially no effects on global DNA methylation of
the human lymphoma cell lines [62]. On the other hand,
treatment of porcine somatic cell nuclear transfer embryos
with HDAC inhibitor oxamflatin downregulated DNMT1
expression and global DNA methylation level in two-cell-
stage embryos [63]. Finally, VPA inhibition of HDAC
increased global DNA methylation in human neuroblast-
oma cell lines [64].
Our results demonstrated that stimulation of the model
cell line with TNF-α and PMA or with SAHA contributed
to de novo DNA methylation of the 5’ LTR. Several studies
in a human cell line or mouse model manifested an uncon-
ventional role of NF-κB as a transcriptional repressor that
mediated DNA methylation by recruiting DNMT1 or
DNMT3B to the target DNA sequence [65–67]. The re-
cruitment of DNA methyltransferases via NF-κB would
offer a possible mechanism for the accumulation of 5’ LTR
DNA methylation after TNF-α and PMA treatment.
We demonstrated that the depletion of DNMT1, but
not DNMT3B, contributed to a partial loss of 5’ LTR
methylation in the 2D12 cell line. Accordingly, in the
mouse model, it was suggested that DNMT1-dependent
methylation activity, in contrast to DNMT3B, was essen-
tial for maintaining methylation and suppressing retro-
transposon LTRs [68, 69]. We did not test the effect of
DNMT3A depletion on 5’ LTR methylation. Previous
study from our laboratory using avian leucosis/sarcoma
virus-based reporter vector showed that absence of
DNMT3A resulted only in a slight additional decrease
of silencing efficiency in comparison with the knock-
out of DNMT3B alone and DNMT3A scored weaker
than DNMT3B in silencing rescue experiments [70].
In addition, DNMT3A was established to be recruited
by H3K36 me3 histone modification that was enriched
in exon regions compared to introns [71, 72], and we
have previously localized the HIV-1 mini-provirus in
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the 2D12 cell line within the intron of UBQLN1 (ubi-
quilin 1) gene [29].
It was observed in CD4+ T cell lines and in the pri-
mary T cell model of HIV-1 latency that MBD2 is re-
cruited to the second, but not to the first, CpG island of
HIV-1 promoter. Together with MBD2, the HDAC2 was
recruited to the second CpG island. Further, inhibition
of DNA methylation reduced the methylation level of
both CpG islands and abrogated the recruitment of
MBD2 and HDAC2, resulting in partial transcriptional
reactivation [37]. In our experiments, depletion of HDAC2
in the 2D12 cell line induced partial reactivation of the
HIV-1 provirus by NF-κB inducers without changing DNA
methylation level of the first CpG island. Consistently, in
our previous work, we showed that the levels of histone 3
acetylation in the HIV-1 5’ LTR in 2D12 cell line increased
2.3-times after TNF-α and PMA stimulation [29].
We and others have shown previously that HIV-1 5’
LTR DNA methylation in combination with the chroma-
tin structure of the latent HIV-1 5’ LTR tightly controls
reactivation of the provirus. Although the latent provirus
with highly methylated 5’ LTR can be reactivated, the
efficiency of reactivation was lower than for the provirus
with hypomethylated 5’ LTR. After the provirus reactiva-
tion in vivo, the majority of host cells are believed to be
eliminated by the viral cytopathic effect or by the immune
system. In fact, we detected populations of hypermethylated
molecules that were present at a low frequency in the latent
reservoir of HIV-1-infected individuals who were treated
for long periods of time. Reactivation-resistant hypermethy-
lated proviral molecules in the latent reservoir would thus
facilitate long-term survival of the host cells and would
represent the fraction of the latent reservoir with long-
term stability.
Furthermore, the hypermethylated provirus could be
replicated during homeostatic proliferation of cells of
the HIV-1 latent reservoir [73–75]. Clonal expansion of
certain proviral populations of the latent reservoir,
including CD4+ memory cells, was shown to increase
with the time spent on ART [76–78]. In the present
study, after the long-term persistence of the HIV-1
reservoir, we observed populations of highly methylated
molecules and of non-methylated molecules within the
same patient (nos. LT1, LT5, LT10), suggesting the possi-
bility of clonal expansion of hypermethylated 5’ LTR
populations.
Importantly, an analysis by Cohn et al. [78] demon-
strated that the majority of clonally expanded integrated
proviruses are defective and contain mainly deletions or
mutations of the 5’ LTRs. However, Maldarelli et al. [76]
showed that a highly expanded clone of cells produced
HIV virions in sufficient quantity to cause viremia. In
our study, we did not find mutations of CpG dinucleotides,
rearrangements, or polymorphisms to occur preferentially
in highly methylated versus non-methylated 5’ LTR
sequences from HIV-1-infected individuals.
It was observed recently that over 10 % of the integrated
latent proviruses in patients could not be reactivated by
stimulation of T cells harboring HIV-1. Importantly, the
reactivation-resistant fraction of the latent reservoir was
reported to lack inactivating mutations or promoter DNA
methylation and was not integrated into transcriptionally
silent regions [40]. However, in the mentioned study, only
six patients who were treated for 6 years were analyzed for
5’ LTR DNA methylation [40]. Although stochastic
fluctuations of transcription factors were suggested to
play a role in the reactivation of the latent HIV-1 reser-
voir [79], we speculate that the 5’ LTR DNA methyla-
tion of the small population of latent HIV-1 molecules
may further limit the reactivation capacity of the frac-
tion of the latent reservoir.
In our previous study [29], we reported increased 5’
LTR methylation levels in memory CD4+ T cells of six
aviremic HIV-1-infected individuals. The patients were
treated for a period of 4–17 years (median 11.5 years).
More recently, Blazkova et al. [39] reported that the
median frequency of methylated CpGs within the HIV-1
5’ LTR was only 2.4 % (range 0–10 %). The resting CD4+
T cells of 11 aviremic patients who were on therapy for
a median of 2.9 years (maximum 6.6 years) were
analyzed in this case [39]. Both studies used the same
technique of bisulfite sequencing. One of the sources of
variability between the studies may lie in the different
lengths of ART treatment. In the present survey, we
analyzed the HIV-1 latent reservoir in two cohorts with
different durations of treatment; the median treatment
period was 2.3 years for the first cohort and 12.5 years
for the second cohort. Intriguingly, in the cohort of pa-
tients who were treated for the shorter period of time,
we detected 0 to 8 % CpG methylation in the 5’ LTR,
whereas in the long-term-treated cohort, the level
reached 0 to 45 % methylated CpGs. We propose that
the accumulation of 5’ LTR DNA methylation may be
observed in patients on ART with a long-term evolution
of the latent reservoir.
Other sources of variability in the methylation levels
of the HIV-1 latent reservoir could lie in the different
characteristics of patients and different ART regimens.
No significant difference in the plasma viral charge was
detected in the present report between the group of
HIV-1-infected individuals treated for up to 3 years and
the long-term treated individuals (Tables S1 and S2).
Patients from the study [29] showing high methylation
levels of the latent HIV-1 5’ LTR were treated by an ineffi-
cient therapy regimen at the beginning. The same was
true for patients from the long-term-treated cohort in our
present report. We speculate that the inefficient ART regi-
men may influence the accumulation of DNA methylated
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proviruses in the reservoir indirectly, e.g., by affecting
the reservoir size. However, to calculate the impact of
other clinical parameters, a larger cohort of patients
needs to be evaluated.
The mechanisms of HIV-1 latency maintenance are of
crucial importance for therapeutic outcomes. So far, various
efforts to activate the latent provirus using VPA or SAHA
have been insufficient to reduce the latent reservoir size. In
the present study, we focused on the role of 5’ LTR DNA
methylation in long-term HIV-1 latency. We observed de
novo appearance and gradual accumulation of 5’ LTR DNA
methylation in the latent provirus 5’ LTR in an in vitro cell
line model after successive stimulations of cells. Import-
antly, we confirmed the presence of limited numbers of
highly methylated HIV-1 proviruses in the latent reservoir
of patients after long-term persistence. We speculate that
the long-term development of HIV-1 promoter methylation
in the latent reservoir of infected patients contributes to
reservoir persistence under ART treatment. Furthermore,
we speculate that therapeutic attempts to activate the
HIV-1 latent reservoir would contribute, at least in
part, to an increase of 5’ LTR DNA methylation of
certain latent HIV-1 proviruses resulting in an increase
of reservoir stability.
Conclusions
We have shown before that 5‘LTR DNA methylation of
HIV-1 promoter stabilizes the latent state and limits the
reactivation of the provirus. Here, we focused on temporal
development of DNA methylation in HIV-1 promoter. We
demonstrated that stimulation of model CD4+ T cell line
with TNF-α and PMA or with SAHA contributed, at least
in part, to accumulation of DNA methylation of the HIV-1
promoter. We further showed that accumulation of 5‘LTR
DNA methylation occured also in the resting CD4+ T cells
of HIV-1-infected individuals characterized by the long-
term existence of the latent reservoir. Further, a limited
fraction of the long-term latent reservoir within some
patients contained the highly methylated HIV-1 pro-
moters that could represent the reactivation-resistant
fraction of the latent reservoir. We speculate that the
stimulation of cells harboring the latent HIV-1 provirus
may contribute to increase of DNA methylation level of
the HIV-1 promoter and therefore may contribute to
the persistence of the reservoir.
Methods
Ethics statement
This study was conducted according to the principles
expressed in the Declaration of Helsinki. Each patient
provided informed written consent to participate in this
study in accordance with institutional and regulatory
guidelines. The study was approved by the Ethics Com-
mittee of the Hospital Na Bulovce in Prague.
Patients
Seropositive individuals were selected for the study on
the basis of the length of ART treatment and low viral
load (<320 HIV-1 RNA copies per milliliter of plasma as
determined with COBAS AmpliPrep/COBAS TaqMan
HIV-1 Test, version 2.0, Roche).
Cell culture and stimulation
The H12 cell line was kindly provided by E. Verdin. The
cell line was described previously [80]. The 2D12 cell
line was prepared by stimulation of the H12 cell line
with TNF-α and PMA and subsequent single-cell sorting
of EGFP-negative cells and clonal selection [29].
Cells were grown in RPMI 1640 medium containing
2 mM L-glutamine (Sigma-Aldrich) supplemented with
10 % fetal bovine serum, 100 U/ml penicilin and 100 μg/ml
streptomycin at 37 °C under a 95 % air/5 % CO2 atmos-
phere. To reactivate the HIV-1 provirus, we treated the cell
lines with 10 nM PMA (Sigma-Aldrich) and 10 ng/ml
TNF-α (Sigma-Aldrich) or with 0.5 μM SAHA (Sigma-
Aldrich) for 24 h. Reactivation was assayed immediately
after the 24 h of treatment.
Flow cytometry analysis
We analyzed EGFP-positive and anti-CD69-phycoerythrin-
labeled (Miltenyi Biotec) viable cells that were negative for
staining with Hoechst 33258 (Invitrogen) at 1 μg/ml with
an LSRII flow cytometer (BD Biosciences). Further
analysis of flow cytometry data was carried out using
FlowJo software.
EGFP-negative cells were isolated using an Influx
high-speed cell sorter (BD Biosciences).
siRNA transfection
Specific ON-TARGETplus SMARTpool siRNAs against
DNMT1, DNMT3B, HDAC1 and HDAC2 genes, along
with a negative control, ON-TARGETplus Non-targeting
siRNAs, were purchased from Dharmacon (GE Healthcare
Life Sciences). The Lipofectamine RNAiMAX transfection
reagent (Life Technologies) was used for siRNA transfec-
tion. The amount of 6 × 105 2D12 cells were seeded into 6-
well plates and mixed with the siRNA-complex consisting
of 90 pmol of specific siRNA SMARTpool or non-targeting
negative control- and the lipofectamine RNAiMAX trans-
fection reagent. Three or 6 days after the transfection, the
cells were collected to analyze the efficiency of knockdown
by Western blot analysis, relative quantitative RT-PCR, or
to perform TNF-α and PMA stimulations and DNA
isolations. Transfection efficiency was assessed to be
40 % according to the transfection efficiency of FITC-
labeled BLOCK-iT™ Fluorescent Oligo (Invitrogen).
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Western blot analysis
Thirty micrograms of total protein was loaded on 8 % SDS
polyacrylamide gel and transferred to polyvinylidene
difluoride membrane, which was consequently blocked in
5 % BSA. The membrane was then probed with 1:1000
dilution of Anti-DNMT1 antibody [EPR3522] (ab92314)
(Abcam) or 1:250 dilution of anti-DNMT3B antibody
[52A1018] (Abcam), HRP-conjugated secondary anti-
rabbit antibody (Cell Signaling Technology), and anti-
mouse antibody (Cell Signaling Technology). The
luminescent reaction was conducted using LumiGLO
(Cell Signaling Technology). Equal protein loading and
transfer was verified by monoclonal Anti-γ-Tubulin, Clone
GTU-88 (Sigma-Aldrich) on the same membrane.
Quantitative RT-PCR
Total RNA was isolated from approximately 2 × 106 cells
using RNAzol RT (Molecular Research Center, Inc.).
One microgram of total RNA was reverse-transcribed
using random primers (Promega) and ProtoscriptII
Reverse Transcriptase (New England BioLabs). Gene
expression was then evaluated by relative quantitative
RT-PCR (qRT-PCR) using the MESA GREEN qPCR
Master Mix Plus for SYBR Assay (Eurogentec) in a
C1000 Touch thermal cycler (Bio-Rad). See Additional
file 9: Table S3 for the primer sequences. All reactions
were run in triplicate, and the average Cts were used for
quantitation. Signals were normalized to the correspond-
ing RNA polymerase II, polypeptide A (POLR2A) house-
keeping gene controls. The relative quantification of the
target genes was determined using the ΔΔCt method.
The negative controls contained water instead of a tem-
plate. All quantitative RT-PCRs were performed in tripli-
cates. Data analysis was conducted with the aid of the
CFX Manager software version 3.1 (Bio-Rad).
Preparation of resting and memory CD4+ T cells from
PBMCs of HIV-1-infected patients
Patients’ PBMCs were separated using a BD Vacutainer
CPT™ Cell Preparation Tube (BD Medical). PBMCs were
separated by density gradient centrifugation of blood
samples. Separated PBMCs were washed twice with PBS
and used for further preparation. CD4+ T cells were
separated from PBMCs by means of CD4+ T Cell Isola-
tion Kit (Miltenyi Biotec). Non-CD4+ cells were labeled
using a cocktail of biotin-conjugated antibodies (against
CD8, CD14, CD15, CD16, CD19, CD36, CD56, CD123,
TCRγ/δ, and CD235a). Subsequently, non-CD4+ cells
marked with biotin were magnetically labeled with anti-
biotin microbeads. CD4+ T cells were isolated by deple-
tion of magnetically labeled cells. In the second step, the
activated CD4+ T cells were labeled for activation markers
with anti-CD25-PE, anti-CD69-PE, and anti-HLA-DR-PE
(all Miltenyi Biotec). Marked cells were magnetically labeled
with anti-PE microbeads. Resting CD4+ T cells were iso-
lated by depletion of magnetically labeled activated CD4+ T
cells. The purity of resting CD4+ T cells determined by
FACS analysis was greater than 95 %. Memory CD4+ Tcells
were separated from PBMCs in one step by means of a
Memory CD4+ T cell Isolation Kit (Miltenyi Biotec). Naive
CD4+ T cells and non-CD4+ T cells were magnetically
labeled using a cocktail of biotin-conjugated antibodies and
anti-biotin microbeads. Isolation of memory CD4+ T cells
was achieved by depletion of magnetically labeled cells.
Bisulfite cytosine methylation analysis
The samples of total genomic DNA from patients‘ resting
or memory CD4+ T cells or from the H12 and 2D12 cells
were isolated using proteinase K, RNase A, phenol-
chloroform extraction and ethanol precipitation. Two
micrograms of genomic DNA was used for bisulfite
conversion using Epitect Plus DNA Bisufite Kit (Qiagen
Inc.) and eluted in a total of 25 μl of water. Bisulfite-
treated DNA was amplified by nested PCR specific for the
5‘LTR in a 50-μl reaction mixture. The first PCR round
was performed with approximately 120 ng of genomic
DNA; 2 μl from the first round was used for the second
round. See Additional file 10: Table S4 for the primer
sequences. The sense primers contained T and the anti-
sense primers A instead of C in positions complementary
to non-methylable C (i.e., C out of CpG dinucleotides).
Cycling conditions are described in Additional file 11. At
least three primary PCRs were performed for each sample
to exclude amplification of one template molecule. Taking
into account that approximately one resting CD4+ T cell
out of 100–1000 contains integrated HIV-1 provirus, we
placed about 10–100 proviruses into each PCR amplifica-
tion. However, bisulfite treatment is known to cause
significant fragmentation of DNA and the final number of
template proviral molecules in one primary PCR reaction
should be <10–100. Ten proviral templates represented
the approximate detection threshold of bisulfite conver-
sion followed by nested PCR as determined by dilution of
the genomic DNA isolated from the H12 cell line. Non-
converted DNA did not provide bands. Several non-
template controls were included in each bisulfite PCR
reaction. Amplification products were cloned in the
pGEM-T-EasyVector System (Promega, Madison, WI)
and sequenced. Analysis was performed using the
Quma (Quantification tool for Methylation Analysis)
software http://quma.cdb.riken.jp/. Only PCR clones
with at least 95 % conversion of cytosines outside CpGs
were taken into account. When more converted mole-
cules with identical sequences were obtained, only one
was used for calculation of the methylated CpG per-
centage to minimize the bias originating from the pref-
erential amplification of one molecule.
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Statistical analysis
Statistical analysis of continuous data was performed using
Kruskal-Wallis non-parametric test (GraphPad Prism 5.04
software), the non-paired Student’s t test, and Mann-
Whitney test. Statistical analysis of binary data was per-
formed using Fisher’s exact test http://www.measuringu.
com/ab-calc.php. The logistic model for the dependence of
5‘LTR DNA methylation levels on time was fitted in the
statistical software R. Significance of the association was
tested by the standard (Wald) test. The corresponding p
values are indicated in the figure legends.
Additional files
Additional file 1: Figure S1. High levels of DNA methylation of proviral
5’ LTR remain stable after repeated cellular stimulation of the 2D12 cell
line. Capacity to decrease 5’ LTR DNA methylation level associated with
increased reactivation capacity of the highly methylated proviral promoter
was assessed. Repeated stimulations of the 2D12 cell line with TNF-α and
PMA were performed with or without the selection of EGFP-positive cells by
FACS-sorting. In contrast to the increase of DNA methylation of the proviral 5’
LTR in the H12 cell line, the high levels of 5’ LTR DNA methylation in the 2D12
cell line did not decrease after repeated cellular stimulations neither
did percentage of EGFP-positive 2D12 cells increase. At the time of
each stimulation, HIV-1 provirus reactivation after 24-h of TNF-α and
PMA treatment was assessed according to the percentage of EGFP-
positive cells. Bisulfite sequence determined the level of 5’ LTR CpG
methylation. Bisulfite sequencing of the 5’ LTR was performed at 24
days after each stimulation, when the cells were restored to the non-
stimulated, steady state. (A) Latent HIV-1 provirus CpG methylation
levels in the 2D12 5’ LTR sequences after repeated stimulations of cells.
The percentage of methylated CpGs in the 5’ LTR was determined by
bisulfite sequencing. The number of successive stimulations is depicted
on the x-axis whereas the mean percentage of methylated CpGs is
depicted on the y-axis. The solid line shows activations without selection of
EGFP-positive cells, and the dashed line indicates activations followed
by selection of EGFP-positive cells. (B) Latent HIV-1 provirus reactivation
in the 2D12 cell line after repeated stimulations of cells. The 2D12 cell
line was stimulated with TNF-α and PMA for 24 h, and the percentage of
EGFP-positive cells was determined by FACS. The number of successive
stimulations is depicted on the x-axis, and the percentage of EGFP-positive
cells is depicted on the y-axis. The solid line shows activations without
selection of EGFP-positive cells whereas the dashed line indicates activations
followed by selection of EGFP-positive cells. (TIF 313 kb)
Additional file 2: Figure S2. Proviral activation and cellular stimulation
of the H12 cell line after TNF-α and PMA or SAHA treatment. The H12 cell
line was stimulated for 24 h with TNF-α and PMA (upper dot plot) or with
SAHA (lower dot plot). EGFP fluorescence representing provirus reactivation is
depicted on x-axis. PE-labeled-CD69 immunofluorescence representing cellular
stimulation is depicted on y-axis. Representative experiment is presented.
(TIF126 kb)
Additional file 3: Figure S3. Hypermethylation of 5’ LTR DNA in the
HIV-1 latency model cell line 2D12 is maintainted by DNMT1. Latent
HIV-1 provirus reactivation levels after 6 days of DNMT1 knockdown.
2D12 cells were transfected with siCTRL or with siDNMT1. The upper
row of histograms represents analyses without cellular stimulation
whereas the lower row represents histograms after 24 h of TNF-α and
PMA stimulation. EGFP fluorescence representing provirus reactivation
is depicted on x-axis; PE-labeled-CD69 immunofluorescence representing
cellular stimulation is depicted on y-axis. Representative experiment is
presented. p values were calculated by the non-paired Student’s t test from
three independent experiments. Significance *** was assigned for p
values <0.001. (TIF 206 kb)
Additional file 4: Figure S4. mRNA expression of histone deacetylases
in the 2D12 cell line. HDAC1, HDAC2, HDAC3, and HDAC8 relative mRNA
levels in the non-stimulated 2D12 cells and 2D12 cells stimulated for 24 h
with TNF-α and PMA were determined by qRT-PCR. mRNA expression was
normalized to the expression of RNA polymerase II, polypeptide A (POLR2A)
housekeeping gene. Data are presented as a mean ± SD of triplicates.
The p values were calculated by the non-paired Student’s t test. Significance
was assigned as follows: ** for p values <0.01, *** for p values <0.001.
(TIF 63 kb)
Additional file 5: Table S1. HIV-1-infected patients treated for up to
3 years. (PDF 162 kb)
Additional file 6: Figure S5. 5’ LTR CpG methylation of the HIV-1
provirus in the latent reservoir of infected patients who were treated for
up to 3 years. (A) 5’ LTR methylation profiles of HIV-1-infected individuals,
nos. 1 to 15, are presented. Individual no. 3 was analyzed after 20 and
30 months of the therapy. The methylation levels are presented as a
mean percentage of methylated CpGs (mCpGs) in HIV-1 promoters. An
analysis of promoter molecules is shown as a linear array of open circles
representing non-methylated CpG residues and closed circles representing
methylated CpG residues. Each line represents one sequenced molecule of
the 5’ LTR. The rectangle schematically represents the 5’ LTR region U3 with
a distribution of individually analyzed CpG dinucleotides and transcription
factor binding sites. (B) Levels of HIV-1 5’ LTR methylation in patients who
were treated for up to 3 years. Each diamond represents one patient,
numbers of patients are indicated corresponding to Additional file 5:
Table S1. The time (months) spent undergoing therapy is depicted on
the x-axis whereas the percentage of methylated CpGs in the HIV-1 5’
LTR in the latent reservoir of infected patients is depicted on the y-axis.
The methylation levels are presented as a mean percentage of methylated
CpGs in HIV-1 promoters. (TIF 539 kb)
Additional file 7: Table S2. HIV-1-infected patients treated for long-term.
(PDF 166 kb)
Additional file 8: Figure S6. Model describing dependence of 5‘LTR
DNA methylation levels in the latent reservoir of HIV-1-infected individuals
on time. Patients treated for up to 3 years and long-term-treated patients
were analyzed as one group. One out of the 25 analyzed HIV-1-infected
persons was deleted due to its outlyingness. The odds ratio (OR) corresponding
to one year difference in length of treatment was estimated to be
1.075 (p < 0.001). The estimated formula describing dependence of
proportion [methylated CpGs] on time is logit(p) = −3.6910 + 0.0727 t,
where p is proportion of [methylated CpGs] after t years of treatment.
(TIF 572 kb)
Additional file 9: Table S3. Primers used for qPCR reactions. (PDF 167 kb)
Additional file 10: Table S4. Primers used for bisulfite-specific PCR
reactions. (PDF 141 kb)
Additional file 11. Supplementary methods. (PDF 81 kb)
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